Google Gemini struggles to write code, calls itself “a disgrace to my species” Google still trying to fix "annoying infinite looping bug," product manager says.

SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

From Anthropic to Replit, these are the key vibe-coding players to follow.